A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8
STRIDE-8 是一项 3 期随机试验，旨在研究成人特异性肺炎球菌结合疫苗 V116 在 18-64 岁未接种过肺炎球菌疫苗且肺炎球菌疾病风险增加的成年人中的安全性、耐受性和免疫原性。
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf604
Scott, Paul T; Pathirana, Jayani; Kato, Akira; Tytus, Richard; Perez, Carlos M; Gilchrist, Nigel Leslie; Kanou, Hidemi; Ha Yoo, Kwang; Kania, Grzegorz; Nissen, Michael; Russell, Amy Falk; Fernsler, Doreen; Waleed, Muhammad; Li, Jianing; Buchwald, Ulrike K; Platt, Heather L
